Financials
- Market Capitalization 1.77 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-25.35
Fiyat/satışlar oranı
26.85
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2023 | ZYME Zymeworks Inc. - Common Stock | 25.13 USD | -0.79% | -2.75% | -6.23% | +41.66% | 1.78 B USD | ||
| 2024 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.50 USD | -3.33% | -5.37% | -21.88% | +30.89% | 1.78 B USD | ||
| 2032 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 16.70 USD | -4.24% | -3.19% | -18.73% | -22.61% | 1.76 B USD | ||
| 2037 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.71 USD | -4.96% | -19.35% | +2.76% | +109.03% | 1.74 B USD |